4-Quinolone interactions with gyrase subunit B inhibitors

References

1. Drlica K, Franco RJ. Inhibitors of DNA topoisomerases. Biochemistry 1988; 27:2253–2259
   [Google Scholar]
2. Hopewell R, Oram M, Briesewitz R, Fisher LM. DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins implications for 4-quinolone action and resistance. J Bacterial 1990; 172:3481–3484
   [Google Scholar]
3. Sreedharan S, Oram M, Jensen B, Petersen LR, Fisher LM. DNA gyrase gyr A mutations in ciprofloxacin-resistant strains of Staphylococcus aureus; close similarity with quinolone-resistance mutations in Escherichia coli. J Bac-teriol 1990; 172:7260–7262
   [Google Scholar]
4. Shen LL, Mitscher LA, Sharma PN. et al. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a co-operative drug-DNA binding model. Biochemistry 1989; 28:3886–3894
   [Google Scholar]
5. Chao L. An unusual interaction between the target of nalidixic acid and novobiocin. Nature 1978; 271:385–386
   [Google Scholar]
6. Neu HC, Chin N-X, Labthavikul P. Antibacterial activity of coumermycin alone and in combination with other antibiotics. Antimicrob Agents Chemother 1984; 25:687–689
   [Google Scholar]
7. Perrone CM, Malinverni R, Glauser MP. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin Al and ciprofloxacin, alone or in combination. Antimicrob Agents Chemother 1987; 31:539–543
   [Google Scholar]
8. Smith JT, Lewin CS. Chemistry and mechanisms of action of the quinolone antibacterials. Andriole VT. ed The quinolones London: Academic Press; 198823–82
   [Google Scholar]
9. Lewin CS, Smith JT. Interactions of 4-quinolones with other antibacterials. J Med Microbiol 1989; 29:221–227
   [Google Scholar]
10. Ratcliffe NT, Smith JT. Effects of magnesium on the activity of 4-quinolone antibacterial agents. J Pharm Pharmacol 1983; 35:61P
    [Google Scholar]
11. Ratcliffe NT, Smith JT. Ciprofloxacin’s bactericidal and inhibitory activity in urine. Chemioterapia 1985; 4:Suppl 2385–386
    [Google Scholar]
12. Lewin CS, Smith JT. Bactericidal mechanisms of ofloxacin. J Antimicrob Chemother 1988; 22:Suppl C1–8
    [Google Scholar]
13. Drusano GL, Townsend RJ, Walsh TJ, Forrest A, Antal EJ, Standiford HC. A steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination. Antimicrob Agents Chemother 1986; 30:42–45
    [Google Scholar]
14. Lewin CS, Howard BMA, Ratcliffe NT, Smith JT. 4-quinolones and the SOS response. J Med Microbiol 1989; 29:139–144
    [Google Scholar]
15. Wang JC. Interactions between twisted DNAs and enzymes: effects of superhelical turns. J Mol Biol 1974; 87:797–816
    [Google Scholar]
16. Lewin CS, Smith JT. Interactions of 4-quinolones with other agents—the importance in assessing antibacterial potency. Crumplin GC. ed The 4-quinolones: antibacterial agents in vitro London: Springer Verlag; 199037–51
    [Google Scholar]
17. Chalkley LJ, Koornhof HJ. Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions. Antimicrob Agents Chemother 1985; 28:331–342
    [Google Scholar]